Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Zaire ebolavirus L polymerase mRNA is the messenger RNA transcript derived from the L gene of the Ebola virus (EBOV). It serves as the essential template for the translation of the Large (L) protein, which functions as the catalytic subunit of the viral RNA-dependent RNA polymerase (RdRp) complex (UniProt: P35263). This complex is indispensable for the viral life cycle, as it mediates both the transcription of viral genes and the replication of the negative-sense RNA genome within the host cell (PubMed: 20511202). Because the L protein is critical for viral survival and lacks a human homolog, its mRNA is a primary target for sequence-specific therapeutic interventions such as small interfering RNAs (siRNAs) and antisense oligonucleotides (PubMed: 20802499). Therapeutic agents like TKM-Ebola (TKM-100-802) utilize lipid nanoparticles to deliver siRNAs that specifically bind to and trigger the degradation of this mRNA via the RNA-induced silencing complex (RISC), thereby preventing the production of the L protein (The Lancet, 2010). By neutralizing the synthesis of the viral replication machinery, these drugs effectively halt the progression of the infection (Nature, 2015).
RNA interference-mediated degradation of viral mRNA or antisense-mediated translation inhibition
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zaire ebolavirus RNA-directed RNA polymerase L mRNA (EBOV L mRNA).